| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 741 |
| 1 | METFORMIN | 724 |
| 2 | METFORMIN ER 500 MG | 603 |
| 3 | METFORMIN ER 750 MG | 603 |
| 4 | FUROSEMIDE | 577 |
| 5 | PEMBROLIZUMAB | 392 |
| 6 | PREDNISONE | 351 |
| 7 | AMLODIPINE | 344 |
| 8 | DUPILUMAB | 335 |
| 9 | SITAGLIPTIN | 319 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIFLORASONE DIACETATE | 6 | 0.0312 |
| 1 | ALOGLIPTIN | 102 | 0.0299 |
| 2 | MIGLITOL | 19 | 0.0198 |
| 3 | DELGOCITINIB | 5 | 0.0186 |
| 4 | ALUMINUM SULFATE TETRADECAHYDRATE, CALCIUM ACETATE MONOHYDRATE | 1 | 0.0169 |
| 5 | NICOTINAMIDE | 40 | 0.0157 |
| 6 | LINAGLIPTIN | 258 | 0.0140 |
| 7 | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | 1 | 0.0115 |
| 8 | CROTAMITON | 7 | 0.0114 |
| 9 | DIFLUPREDNATE OPHTHALMIC | 10 | 0.0113 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1174 |
| 1 | Corticosteroid [EPC] | 813 |
| 2 | Loop Diuretic [EPC] | 628 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 539 |
| 4 | Dihydropyridine Calcium Channel Blocker [EPC] | 436 |
| 5 | Proton Pump Inhibitor [EPC] | 416 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 382 |
| 7 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 371 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 353 |
| 9 | Calcium Channel Blocker [EPC] | 344 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 33 | 0.0480 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1174 | 0.0119 |
| 2 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 371 | 0.0114 |
| 3 | Tubulin Inhibiting Agent [EPC] | 3 | 0.0103 |
| 4 | Glinide [EPC] | 76 | 0.0085 |
| 5 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 6 | Sulfone [EPC] | 65 | 0.0060 |
| 7 | Adenosine Receptor Agonist [EPC] | 44 | 0.0060 |
| 8 | alpha-Glucosidase Inhibitor [EPC] | 29 | 0.0059 |
| 9 | Sclerosing Agent [EPC] | 2 | 0.0044 |